title: Dabigatran may not be an effective anticoagulant for haemodialysis.
authors.forename: Yeoungjee
authors.initials: Y
authors.lastname: Cho
authors.forename: Karen
authors.initials: K
authors.lastname: Mills
authors.forename: Joanna M
authors.initials: JM
authors.lastname: Sturtevant
authors.forename: Peter I
authors.initials: PI
authors.lastname: Pillans
authors.forename: David W
authors.initials: DW
authors.lastname: Mudge
mesh_terms: D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001777:Blood Coagulation / Q000187:drug effects*; D000069604:Dabigatran; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D011725:Pyridines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006435:Renal Dialysis; D017211:Treatment Failure
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D000069604:Dabigatran